Sign inJoin waitlistJoin the waitlist

Carmen Landaverde

Assistant Professor of Medicine, Transplant Hepatologist · University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine

Credentials: · · · · · ·

History

University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
Present

Gastroenterology
University of California-Los Angeles
2007–2010
Transplant Hepatology
Baylor University Medical Center
2006–2007
Ronald Reagan UCLA Medical Center
2003–2006
University of California, Davis, School of Medicine
1999–2003

Research

Patients with NASH and cryptogenic cirrhosis are less likely than those with hepatitis C to receive liver transplants
Clinical Gastroenterology and Hepatology · 2011 · 76 citations
Short-duration treatment with elbasvir/grazoprevir and sofosbuvir for hepatitis C: A randomized trial
Hepatology · 2017 · 61 citations
Fluid retention in cirrhosis: pathophysiology and management
Review · QJM · 2008 · 60 citations

Fred Poordad
9 papers
Jennifer Wells
8 papers
Eric Lawitz
7 papers
Julio Gutierrez
5 papers · 2 as a fellow
FD
Francisco Durazo
4 papers
Ronald Busuttil
4 papers
Fabian Rodas
3 papers
James Tabibian
3 papers · 3 as a resident
Sammy Saab
3 papers
BH
Bryan Hanysak
2 papers
Eugenia Tsai
2 papers
GD
Gary Davis
2 papers

Clinical trials

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2032
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Site PI · Recruiting · Phase 2
GlaxoSmithKline
2025–2028